UNSPSC 51313705: Zolamine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NXB79TB0N2. European Medicines Agency schedules Zolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00173MIG. Zolamine generally arises in the molecular formula C15H21N3OS.

UNSPSC 51313705 Zolamine is a Commodity code covering pharmaceutical products and medical supplies that state and local governments procure for public health and emergency response initiatives. Recent solicitations show this code capturing opioid-antagonist medications and related drug-management systems rather than zolamine specifically — Seminole County, Florida issued an IFB in mid-2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually to support community health programs, with quarterly deliveries to a county health facility. The scope includes full vendor responsibility for shipping and delivery costs, compliance with drug-free workplace and E-Verify requirements, and a two-year contract term with optional one-year renewal. Insurance requirements (workers' compensation, commercial general liability, professional liability) and a three-month probationary termination period are standard. The solicitation indicates potential FEMA funding and associated federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act, though explicit budget figures and disadvantaged-enterprise set-asides are not specified.

Activity under this code appears limited to isolated county-level health procurement. The single recent opportunity shown is Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023 — the date discrepancy suggests data-quality issues in the underlying record. No additional recent opportunities are visible in the source, and the code shows little evidence of broader state-level, municipal, school-district, or transit-authority activity. Geographic concentration is not assessable from a single Florida solicitation. The mismatch between the code's nominal product (zolamine) and the actual procurement (naloxone and drug deactivation systems) suggests either miscoding at the source or a taxonomy alignment issue worth clarifying before pursuing activity under this classification.